Medical specialists from Norway tagged as investigators in clinical trials studying Breast Neoplasms
Total 17 results
-
Andreas Stensvold, MD, PhDSeen in:
- Kalnes, Sarpsborg, Østfold Hospital
Trials:- NCT03904173 (Principal Investigator)
Conditions: -
Bjørnar Gilje, MD PhDSeen in:
- Stavanger, Stavanger University Hospital
Trials:- NCT02965950 (Principal Investigator)
-
Egil S. Blix, MD PhDSeen in:
- Tromsø, University Hospital of Northern Norway
Trials:- NCT02965950 (Principal Investigator)
-
Evandro F Fang, PhDSeen in:
- Akershus, Lørenskog, Akershus University Hospital
Trials:- NCT05732051 (Sub-Investigator)
-
Hans P Eikesdal, M.D.-Ph.D.Seen in:
- Bergen, Haukeland University Hospital
Trials:- NCT03904173 (Principal Investigator)
Conditions: -
Hans Petter Eikesdal, MD PhDSeen in:
- Hordaland, Bergen, Haukeland University Hospital
Trials:- NCT02965950 (Principal Investigator)
-
Hege Oma Ohnstad, MD PhDSeen in:
- Oslo, Oslo University Hospital
Trials:- NCT03904173 (Principal Investigator)
Conditions: -
Helle Kristine Skjerven, M.D.-Ph.D.Seen in:
- Buskerud, Drammen, Drammen Hospital - Vestre Viken
Trials:- NCT03904173 (Principal Investigator)
Conditions: -
Hilde Krogstad, MD PhDSeen in:
- Sør Trøndelag, Trondheim, St. Olavs hospital
Trials:- NCT02965950 (Sub-Investigator)
-
Jürgen Geisler, MD PhDSeen in:
- Akershus, Lørenskog, Akershus University Hospital
- Lørenskog, Akershus University Hospital
Trials:- NCT02965950 (Principal Investigator)
- NCT05732051 (Sub-Investigator)
-
Sindre Molvær, MDSeen in:
- Hordaland, Bergen, Haukeland University Hospital
Trials:- NCT02965950 (Sub-Investigator)
-
Stian Knappskog, PhDSeen in:
- Hordaland, Bergen, Haukeland University Hospital
Trials:- NCT02965950 (Sub-Investigator)
-
Sunil Raj, MD PhDSeen in:
- Sør Trøndelag, Trondheim, St. Olavs hospital
Trials:- NCT02965950 (Principal Investigator)
-
Tor Jensen, M.D.-Ph.d.Seen in:
- Ulefossveien 55, Skien, Telemark Hospital
Trials:- NCT03904173 (Principal Investigator)
Conditions: -
Torbjørn Omland, MD, PhDSeen in:
- Akershus, Lørenskog, Akershus University Hospital
Trials:- NCT05732051 (Principal Investigator)
-
Turid Aas, MD PhDSeen in:
- Hordaland, Bergen, Haukeland University Hospital
Trials:- NCT02965950 (Sub-Investigator)
Clinical Trials on Breast Neoplasms
-
Emory UniversityEisai Inc.TerminatedBreast Cancer | Breast Neoplasms | Breast Tumors | Neoplasms, Breast | Cancer of the Breast | Tumors, BreastUnited States
-
Innocrin PharmaceuticalCompletedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | Male Breast Cancer | ER+ Breast Cancer | Cancer of the BreastUnited States
-
G1 Therapeutics, Inc.TerminatedBreast Cancer | Breast Neoplasm | Triple-Negative Breast Cancer | Triple-Negative Breast NeoplasmsUnited States, Bulgaria, Croatia, Slovenia, Serbia, Belgium, North Macedonia, Slovakia
-
Seagen Inc.CompletedTriple Negative Breast Neoplasms | Hormone Receptor Positive Breast Neoplasms | HER2 Positive Breast Neoplasms | HER2 Mutations Breast NeoplasmsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Celgene CorporationTerminatedInflammatory Breast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Recurrent Breast Cancer | HER2-negative Breast CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedInflammatory Breast Cancer | Male Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
Providence Health & ServicesBrooklyn ImmunoTherapeutics, LLCActive, not recruitingBreast Neoplasm | Triple Negative Breast Cancer | Breast Neoplasm, MaleUnited States
-
Joseph Baar, MD, PhDCompletedBreast Cancer | Stage I Breast Cancer | Inflammatory Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Triple-negative Breast Cancer | Stage IIIC Breast CancerUnited States
-
Dana-Farber Cancer InstituteConquer Cancer FoundationRecruitingBreast Cancer | Metastatic Breast Cancer | Triple Negative Breast Cancer | HER2-positive Breast Cancer | Inflammatory Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of BreastUnited States
-
Wake Forest University Health SciencesMerck Sharp & Dohme LLCCompletedMale Breast Cancer | Breast - FemaleUnited States